115 related articles for article (PubMed ID: 17302201)
1. Uncovering novel targets for cancer chemoprevention.
Dragnev KH; Feng Q; Ma Y; Shah SJ; Black C; Memoli V; Nugent W; Rigas JR; Kitareewan S; Freemantle S; Dmitrovsky E
Recent Results Cancer Res; 2007; 174():235-43. PubMed ID: 17302201
[TBL] [Abstract][Full Text] [Related]
2. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
3. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
4. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.
Dragnev KH; Pitha-Rowe I; Ma Y; Petty WJ; Sekula D; Murphy B; Rendi M; Suh N; Desai NB; Sporn MB; Freemantle SJ; Dmitrovsky E
Clin Cancer Res; 2004 Apr; 10(7):2570-7. PubMed ID: 15073138
[TBL] [Abstract][Full Text] [Related]
5. Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention.
Pitha-Rowe I; Petty WJ; Feng Q; Koza-Taylor PH; Dimattia DA; Pinder L; Dragnev KH; Memoli N; Memoli V; Turi T; Beebe J; Kitareewan S; Dmitrovsky E
Cancer Res; 2004 Nov; 64(21):8109-15. PubMed ID: 15520223
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 as a target for chemoprevention.
Petty WJ; Dragnev KH; Dmitrovsky E
Lung Cancer; 2003 Aug; 41 Suppl 1():S155-61. PubMed ID: 12867074
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism.
Langenfeld J; Kiyokawa H; Sekula D; Boyle J; Dmitrovsky E
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12070-4. PubMed ID: 9342364
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells.
Boyle JO; Langenfeld J; Lonardo F; Sekula D; Reczek P; Rusch V; Dawson MI; Dmitrovsky E
J Natl Cancer Inst; 1999 Feb; 91(4):373-9. PubMed ID: 10050872
[TBL] [Abstract][Full Text] [Related]
9. Retinoid targets in cancer therapy and chemoprevention.
Dragnev KH; Petty WJ; Dmitrovsky E
Cancer Biol Ther; 2003; 2(4 Suppl 1):S150-6. PubMed ID: 14508093
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
Petty WJ; Dragnev KH; Memoli VA; Ma Y; Desai NB; Biddle A; Davis TH; Nugent WC; Memoli N; Hamilton M; Iwata KK; Rigas JR; Dmitrovsky E
Clin Cancer Res; 2004 Nov; 10(22):7547-54. PubMed ID: 15569985
[TBL] [Abstract][Full Text] [Related]
11. Uncovering residues that regulate cyclin D1 proteasomal degradation.
Feng Q; Sekula D; Müller R; Freemantle SJ; Dmitrovsky E
Oncogene; 2007 Aug; 26(35):5098-106. PubMed ID: 17310991
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the epidermal growth factor receptor as a target for lung cancer prevention.
Lonardo F; Dragnev KH; Freemantle SJ; Ma Y; Memoli N; Sekula D; Knauth EA; Beebe JS; Dmitrovsky E
Clin Cancer Res; 2002 Jan; 8(1):54-60. PubMed ID: 11801540
[TBL] [Abstract][Full Text] [Related]
13. Repression of cyclin D1 as a target for germ cell tumors.
Freemantle SJ; Vaseva AV; Ewings KE; Bee T; Krizan KA; Kelley MR; Hattab EM; Memoli VA; Black CC; Spinella MJ; Dmitrovsky E
Int J Oncol; 2007 Feb; 30(2):333-40. PubMed ID: 17203214
[TBL] [Abstract][Full Text] [Related]
14. Cyclin degradation for cancer therapy and chemoprevention.
Freemantle SJ; Liu X; Feng Q; Galimberti F; Blumen S; Sekula D; Kitareewan S; Dragnev KH; Dmitrovsky E
J Cell Biochem; 2007 Nov; 102(4):869-77. PubMed ID: 17868090
[TBL] [Abstract][Full Text] [Related]
15. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation.
Langenfeld J; Lonardo F; Kiyokawa H; Passalaris T; Ahn MJ; Rusch V; Dmitrovsky E
Oncogene; 1996 Nov; 13(9):1983-90. PubMed ID: 8934545
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
[TBL] [Abstract][Full Text] [Related]
17. UBE1L causes lung cancer growth suppression by targeting cyclin D1.
Feng Q; Sekula D; Guo Y; Liu X; Black CC; Galimberti F; Shah SJ; Sempere LF; Memoli V; Andersen JB; Hassel BA; Dragnev K; Dmitrovsky E
Mol Cancer Ther; 2008 Dec; 7(12):3780-8. PubMed ID: 19074853
[TBL] [Abstract][Full Text] [Related]
18. Retinoid chemoprevention trials: cyclin D1 in the crosshairs.
Freemantle SJ; Guo Y; Dmitrovsky E
Cancer Prev Res (Phila); 2009 Jan; 2(1):3-6. PubMed ID: 19139010
[No Abstract] [Full Text] [Related]
19. Cancer chemoprevention by targeting proteasomal degradation: commentary re KA Dragnev et al, Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy. Clin Cancer Res, 2004;10:2570-7.
Yang CS; Chin KV; Lambert JD
Clin Cancer Res; 2004 Apr; 10(7):2220-1. PubMed ID: 15073095
[No Abstract] [Full Text] [Related]
20. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
